ERIN MCALEER: Open Payments
NPI 1194504167 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $232 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 7 | $178 |
| MILLICENT US INC | 3 | $57 |
| Astellas Pharma US Inc | 2 | $56 |
| Sage Therapeutics, LLC | 3 | $54 |
| Gilead Sciences, Inc. | 1 | $34 |
| Exeltis, USA Inc. | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Organon LLC | 1 | $16 |
Products named: Veozah, ZURZUVAE, FEMRING, SLYND, MYFEMBREE, FEMLYV, APTIMA, Flucelvax.
Industry payments across MD — which companies pay providers there.
